Cai, Ling
Liu, Hongyu
Huang, Fang
Fujimoto, Junya
Girard, Luc
Chen, Jun
Li, Yongwen http://orcid.org/0000-0001-6102-2949
Zhang, Yu-An
Deb, Dhruba
Stastny, Victor
Pozo, Karine
Kuo, Christin S.
Jia, Gaoxiang
Yang, Chendong
Zou, Wei
Alomar, Adeeb
Huffman, Kenneth
Papari-Zareei, Mahboubeh
Yang, Lin
Drapkin, Benjamin
Akbay, Esra A. http://orcid.org/0000-0002-4149-2529
Shames, David S.
Wistuba, Ignacio I.
Wang, Tao http://orcid.org/0000-0002-4355-149X
Johnson, Jane E. http://orcid.org/0000-0002-8605-2746
Xiao, Guanghua
DeBerardinis, Ralph J. http://orcid.org/0000-0002-2705-7432
Minna, John D. http://orcid.org/0000-0002-7776-0767
Xie, Yang
Gazdar, Adi F.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U01CA213338, P50CA070907, 5P30CA142543)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM115473)
Cancer Prevention and Research Institute of Texas (RP180805)
Article History
Received: 7 December 2020
Accepted: 9 February 2021
First Online: 9 March 2021
Competing interests
: J.D.M. receives licensing fees from the NCI and UT Southwestern to distribute cell lines. R.J.D. is on the advisory board for Agios Pharmaceuticals. D.S.S. and W.Z. are currently employed by Genentech Inc. and own stock in Roche Holdings. I.I.W. is a speaker at Medscape, MSD, Genentech/Roche, PlatformQ Health, Pfizer, AstraZeneca, Merck; receives research support from Genentech, Oncoplex, HTG Molecular, DepArray, Merck, Bristol-Myers Squibb, Medimmune, Adaptive, Adaptimmune, EMD Serono, Pfizer, Takeda, Amgen, Karus, Johnson & Johnson, Bayer, Iovance, 4D, Novartis, and Akoya; and is on the advisory boards for Genentech/Roche, Bayer, Bristol-Myers Squibb, AstraZeneca/Medimmune, Pfizer, HTG Molecular, Asuragen, Merck, GlaxoSmithKline, Guardant Health, Oncocyte, and MSD. The remaining authors declare no competing interests.